<DOC>
	<DOCNO>NCT01134705</DOCNO>
	<brief_summary>The purpose study assess efficacy safety investigational nasal aerosol compare placebo nasal aerosol treatment perennial allergic rhinitis .</brief_summary>
	<brief_title>Study Adult Adolescent Subjects With PAR ( Perennial Allergic Rhinitis )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Informed Consent Documented history perennial allergic rhinitis A demonstrated sensitivity least one allergen know induce PAR standard skin prick test . Minimum subjectreported reflective total nasal symptom score ( rTNSS ) least 6 ( possible 12 ) Other criterion apply History physical finding nasal pathology ( within 60 day prior screen visit ) Participation investigational drug study 30 day precede screen visit History respiratory infection/disorder 14 day precede screen visit runin period Use prohibit concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>